Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN)

Clinical trial NCT00612105 · COMPLETED

Trial details

NCT number: NCT00612105
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Postherpetic Neuralgia

Start date: 2007-10-01
Primary completion: 2009-05-01
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.